Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Synta Pharmaceuticals Inc. (SNTA)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: SNTA
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
1 new
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Analysis - Latest Articles
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
Justin M. Hall
•
Sep 20
•
3 Comments
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
Justin M. Hall
•
Sep 11
•
23 Comments
Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly
Mark Cifra
•
Apr 02
•
5 Comments
Morphosys: A Biotech Rule Breaker (Part 2)
Ohad Hammer
•
Mar 30
•
Comment!
Chink in the Biotechnology Armor
Michael Becker
•
Mar 01
•
4 Comments
Friday's Options Recap
Frederic Ruffy
•
Feb 13
•
1 Comment
More articles on SNTA »
Latest Transcript
Synta Pharmaceuticals Corp. Q3 2009 Earnings Call Transcript
Wed November 4, 2009
More transcripts on SNTA »
Instablogs
Spectrum Pharmaceuticals: $50 Million Vote of Confidence or Cause for Concern
Fri September 18, 2009
•
Justin M. Hall
•
15 Comments
Spectrum Pharmaceuticals: Post Zevalin Approval Sales Should Ramp Up
Fri September 11, 2009
•
Justin M. Hall
•
10 Comments
Write a post on SNTA
|
More Instablogs on SNTA »
Sentiment
What advice would you give to
SNTA?
123 characters left
What's your view of SNTA?
Make sure you include SNTA
140 characters left
|
Settings